IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
Clinical trial NCT04136028 · COMPLETED
Trial details
- NCT number
- NCT04136028
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-25
- Primary completion
- 2019-01-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.